AAS
TNYA icon

Ameritas Advisory Services’s Tenaya Therapeutics TNYA Stock Holding History

Ameritas Advisory Services’s Portfolio TNYA Stock Details TNYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.7K Buy
+5,000
New +$3.8K ﹤0.01% 1606
2025
Q4 		– Sell
-5,000
Closed -$8.1K – 2003
2025
Q3 		$8.1K Hold
5,000
– – ﹤0.01% 1727
2025
Q2 		$3.06K Buy
+5,000
New +$2.54K ﹤0.01% 2387

Other funds holding TNYA

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EAM
Empery Asset Management New York $86.5M AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
BGM
Burkehill Global Management New York $2.77B AUM 65.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Ameritas Advisory Services's TNYA Position: Q2 2026 in Review

Ameritas Advisory Services opened a new position in Tenaya Therapeutics (TNYA) in Q2 2026: 5,000 shares worth $3.7K. The stake represents ﹤0.01% of the portfolio and ranks #1606 among its holdings. This is a return to the name: Ameritas Advisory Services previously reported a position in TNYA as recently as Q3 2025.

Ameritas Advisory Services first reported a position in TNYA in Q2 2025 and has held it in 3 quarters since. The position peaked at $8.1K in Q3 2025. 101 funds tracked by Wall St. Rank hold TNYA as of Q2 2026.

  • Ameritas Advisory Services held 5,000 shares of Tenaya Therapeutics worth $3.7K as of Q2 2026.
  • Tenaya Therapeutics was a new Ameritas Advisory Services position in Q2 2026.
  • Tenaya Therapeutics made up ﹤0.01% of Ameritas Advisory Services's portfolio in Q2 2026, its #1606 holding.
  • Ameritas Advisory Services first reported a position in Tenaya Therapeutics in Q2 2025 and has held it in 3 quarters since.
  • Ameritas Advisory Services's Tenaya Therapeutics position peaked at $8.1K in Q3 2025.
  • 101 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q2 2026.

Based on Ameritas Advisory Services's 13F filing for Q2 2026, filed 14 Aug 2026.